These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17378928)

  • 41. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
    Gracia M; Díaz C; Coronel P; Gimeno M; García-Rodas R; Rodríguez-Cerrato V; del Prado G; Huelves L; Ruiz V; Naves PF; Ponte MC; Granizo JJ; Soriano F
    Diagn Microbiol Infect Dis; 2009 May; 64(1):52-6. PubMed ID: 19232860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Group A streptococcus colonies from a single throat swab can have heterogeneous antimicrobial susceptibility patterns.
    Vandevoorde A; Ascenzo S; Miendje Deyi VY; Mascart G; Mansbach AL; Landsberg M; Dreze P; Steer AC; Van Melderen L; Smeesters PR
    Pediatr Infect Dis J; 2013 Mar; 32(3):296-8. PubMed ID: 23249905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
    Pires R; Rolo D; Mato R; Feio de Almeida J; Johansson C; Henriques-Normark B; Morais A; Brito-Avô A; Gonçalo-Marques J; Santos-Sanches I
    FEMS Microbiol Lett; 2009 Jun; 296(2):235-40. PubMed ID: 19486163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The heterogeneity of endemic community pediatric group a streptococcal pharyngeal isolates and their relationship to invasive isolates.
    Haukness HA; Tanz RR; Thomson RB; Pierry DK; Kaplan EL; Beall B; Johnson D; Hoe NP; Musser JM; Shulman ST
    J Infect Dis; 2002 Apr; 185(7):915-20. PubMed ID: 11920315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of antibiotic sensitivity of Streptococcus pyogenes isolated in the hospital milieu (Charles Nicolle hospital of Tunis)].
    el Bour M; Fendri C; Ben Hassen A; Kamoun A; Boudabbous A; Ben Redjeb S
    Med Trop (Mars); 1993; 53(1):13-7. PubMed ID: 8505883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
    Albertí S; Cortés G; García-Rey C; Rubio C; Baquero F; García-Rodríguez JA; Bouza E; Aguilar L
    Antimicrob Agents Chemother; 2005 Jan; 49(1):418-20. PubMed ID: 15616324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythromycin-resistant group A streptococci.
    Linder JA; Stafford RS
    N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
    [No Abstract]   [Full Text] [Related]  

  • 49. Distribution of beta haemolytic streptococci in pharyngitis specimens obtained from children.
    Brook I
    Microbios; 1983; 36(145-46):169-72. PubMed ID: 6346020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. erm(A)-mediated macrolide resistance and ability to invade human respiratory cells in a Streptococcus dysgalactiae subspecies equisimilis pharyngeal isolate.
    Palmieri C; Rätsch IM; Princivalli MS; Candelaresi C; Magi G; Spinaci C; Coppa GV; Facinelli B
    J Antimicrob Chemother; 2007 Dec; 60(6):1405-6. PubMed ID: 17938128
    [No Abstract]   [Full Text] [Related]  

  • 51. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
    Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
    Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
    Yazgi H; Ertek M; Aktaş AE
    Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Characteristics and related factors related to the resistance on antibiotics among group A streptococcus strains isolated from children in Beijing, during May and July 2011].
    Liu S; Li J; Peng XM; Yang P; Zhang DT; Wu SS; Cui SJ; Liu YM; Wang QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Nov; 33(11):1133-8. PubMed ID: 23290898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
    Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
    Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.
    Mihaila-Amrouche L; Bouvet A; Loubinoux J
    J Clin Microbiol; 2004 Aug; 42(8):3844-6. PubMed ID: 15297545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
    Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
    Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group A Streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002.
    Pires R; Rolo D; Gama-Norton L; Morais A; Lito L; Salgado MJ; Johansson C; Möllerberg G; Henriques-Normark B; Gonçalo-Marques J; Santos-Sanches I
    Microb Drug Resist; 2005; 11(4):360-70. PubMed ID: 16359196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics.
    Coonan KM; Kaplan EL
    Pediatr Infect Dis J; 1994 Jul; 13(7):630-5. PubMed ID: 7970952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.